SalvatoreQuintoNapoliMD

Neuroimmunology/Multiple Sclerosis

Medical Director at Neurology Center of New England, PC

Dr. Napoli is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Neuroimmunology & Multiple Sclerosis, 2003 - 2006
Albany Medical CenterResidency, Neurology, 2000 - 2003
Albany Medical CenterInternship, Internal Medicine, 1999 - 2000
Albany Medical CollegeClass of 1999

CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012
Super Doctor SuperDoctors.com

PubMed

Benefits and risks of FDA-approved amyloid-targeting antibodies for treatment of early Alzheimer's disease: Navigating clinician-patient engagement.
Dorene M Rentz, Paul S Aisen, Alireza Atri, Janice Hitchcock, Michael Irizarry
Alzheimer's & Dementia. 2024-11-01
1 citations
Teriflunomide levels in women whose male sexual partner is on teriflunomide for relapsing multiple sclerosis
Joseph B. Guarnaccia, Ann Cabot, Lore Garten, Salvatore Napoli, Mayer J. Hasbani
Multiple Sclerosis and Related Disorders. 2021-10-28
6 citations
A New England COVID-19 Registry of Patients With CNS Demyelinating Disease: A Pilot Analysis.
Kelli M. Money, Ashmanie Mahatoo, Soleil Samaan, Pria Anand, Ursela Baber
Neurology(R) Neuroimmunology & Neuroinflammation. 2021-08-02

Salvatore Napoli, MD, a Neurologist with Neurology Center of New EnglandSeptember 6th, 2019
5 Reasons You Get Those Annoying Morning HeadachesJuly 25th, 2017